EHS
EHS

STAT Plus: Cummings probes Trump administration official over potential conflicts with drug maker

A Congressional lawmaker is investigating the role that a former Gilead Sciences (GILD) lobbyist played in the Trump administration and its efforts to develop a payment model for a pricey new Novartis cancer drug.

The focus of the inquiry is Joseph Grogan, who joined the Trump administration in early 2017 as associate director of health programs at the Office of Management and Budget, where he was working on a “pay-for-performance” program for the Novartis (NVS) drug, called Kymriah.

Continue to STAT Plus to read the full story…

EHS

Leave a Reply

Your email address will not be published.

Back to top button